Cost Effectiveness of Tofacitinib for the Treatment of Active Ankylosing Spondylitis in Greece.

Autor: Gourzoulidis G; Health Through Evidence, Agiou Panteleimonos 25, 17456, Athens, Greece. gourzoulidis@hte.gr., Solakidi A; Pfizer Hellas, Athens, Greece., Psarra M; Health Through Evidence, Agiou Panteleimonos 25, 17456, Athens, Greece., Nikitopoulou E; Pfizer Hellas, Athens, Greece., Tzanetakos C; Health Through Evidence, Agiou Panteleimonos 25, 17456, Athens, Greece.

Publikováno v: Clinical drug investigation [Clin Drug Investig] 2024 Jan; Vol. 44 (1), pp. 59-69. Date of Electronic Publication: 2023 Dec 16.

EE61 Burden of Respiratory Syncytial Virus Disease in Infants and the Potential Value of Maternal Immunization in Greece

Autor: Solakidi, A ¹, Barmpouni, M ¹, Psarra, M ², Detsis, M ¹, Markatis, E ¹, Tzanetakos, C ², Gourzoulidis, G ²

Publikováno v: In Value in Health December 2024 27(12) Supplement:S65-S65

EE481 Cost-Effectiveness Analysis of Upadacitinib in Patients with Moderately to Severely Active Ulcerative Colitis in Greece

Autor: Tzanetakos, C., Psarra, M., Kotsis, I., Gourzoulidis, G.

Publikováno v: In Value in Health December 2023 26(12) Supplement:S144-S144

EE95 Cost-Effectiveness Analysis of Pemigatinib for the Treatment of Adult Patients with Locally Advanced or Metastatic Cholangiocarcinoma with a FGFR2 Fusion or Rearrangement That Have Progressed After Systemic Therapy in Greece

Autor: Tzanetakos, C., Psarra, M., Batsi, M., Patterson, K., Vostitsanou, Z., Gourzoulidis, G.

Publikováno v: In Value in Health December 2023 26(12) Supplement:S69-S69

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.